We previously performed whole exome and targeted re-sequencing of 58 sporadic and Gorlin’s Syndrome BCC samples and found expected mutations in PTCH1 and SMO in accordance with our previous publications [6,7]. This evidence concerns the gene PTCH1 and skin basal cell carcinoma.